Fig. 2From: Decreased level of serum NT-proCNP associates with disease severity in COVID-19NT-proCNP levels. NT-proCNP levels on admission were significantly decreased in the COVID-19 group (n = 32) compared to the non-COVID-19 group (n = 35). Pairwise between-groups difference reached significance (Wilcoxon’s rank-sum test). COVID-19 coronavirus disease 2019, NT-proCNP amino terminal pro-C-typeBack to article page